Zeidan Ryan 4
4 · Millendo Therapeutics, Inc. · Filed Aug 20, 2019
Insider Transaction Report
Form 4
Zeidan Ryan
Chief Development Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-08-19+10,000→ 10,000 totalExercise: $7.27Exp: 2029-08-18→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on August 19, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.